John

Biography

John brings more than twenty years of big pharma and biotech experience to 4D Pharma. Most recently John served as Chief Operating Officer for Veloxis Pharmaceuticals A/S where he led the successful efforts to develop and launch the company’s novel immunosuppressant agent, Envarsus. Prior to joining Veloxis, John served in roles of increasing responsibility across multiple therapeutic areas, including oncology, haematology and auto-immune diseases at Novartis, Enzon and Wyeth. John received his medical training at the University of the Witwatersrand School of Medicine, Johannesburg, South Africa, and his MBA degree from INSEAD in Fontainebleau, France.

Research Interest

Oncology